Updating results

644 results

Sort: Relevance | Date

Upadacitinib for treating moderate to severe rheumatoid arthritis [ID1400]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 21 February 2020.

Technology appraisal guidance In consultation

Lorlatinib for treating ALK-positive advanced non-small-cell lung cancer [ID1338]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 18 February 2020.

Technology appraisal guidance In consultation

Implanted vagus nerve stimulation for treatment-resistant depression: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 20 February 2020.

Interventional procedures guidance In consultation

Electrical stimulation to improve muscle strength in non-neurological chronic conditions: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 05 March 2020.

Interventional procedures guidance In consultation

Faltering growth: quality standard consultation

We are listening to your views on this quality standard. Comments close 21 February 2020.

Quality standard In consultation

Behaviour change: digital and mobile health interventions: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 06 March 2020.

NICE guideline In consultation

Preterm labour and birth: surveillance consultation

We are listening to your views on this NICE guideline. Comments close 26 February 2020.

NICE guideline In consultation

Axonics sacral neuromodulation system for bladder control in people with symptoms of overactive bladder: draft guidance

We are listening to your views on this medical technologies guidance. Comments close 13 March 2020.

In consultation

Pembrolizumab with axitinib for untreated advanced renal cell carcinoma [ID1426]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 04 March 2020.

Technology appraisal guidance In consultation

Suspected neurological conditions: quality standard consultation

We are listening to your views on this quality standard. Comments close 11 March 2020.

Quality standard In consultation

Esketamine for treatment-resistant depression (ID1414): appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 18 February 2020.

Technology appraisal guidance In consultation

Acute coronary syndromes: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 27 March 2020.

NICE guideline In consultation

Faltering growth

In development [GID-QS10083] Expected publication date: 02 June 2020

Quality standard In development

Community pharmacies: promoting health and wellbeing

In development [GID-QS10115] Expected publication date: 02 June 2020

Quality standard In development

Crisaborole for treating mild to moderate atopic dermatitis in people aged 2 years and older (ID1195)

In development [GID-TA10435] Expected publication date: 03 June 2020

Technology appraisal guidance In development

Suspected neurological conditions

In development [GID-QS10082] Expected publication date: 03 July 2020

Quality standard In development

Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke

In development [GID-DG10023] Expected publication date: 27 May 2020

Diagnostics guidance In development

QAngio XA 3D/ QFR and CAAS vFFR imaging software for assessing the functional significance of coronary obstructions during invasive coronary angiography

In development [GID-DG10034] Expected publication date: 30 September 2020

Diagnostics guidance In development

Nintedanib for treating interstitial lung disease caused by systemic sclerosis (ID1420)

In development [GID-TA10427] Expected publication date: TBC

Technology appraisal guidance In development

Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after initial platinum-based chemotherapy [ID1518]

In development [GID-TA10504] Expected publication date: TBC

Technology appraisal guidance In development

Carfilzomib with dexamethasone and lenalidomide for treating multiple myeloma after at least 1 previous therapy [ID1493]

In development [GID-TA10510] Expected publication date: TBC

Technology appraisal guidance In development

Acalabrutinib for treating chronic lymphocytic leukaemia ID1613

In development [GID-TA10532] Expected publication date: TBC

Technology appraisal guidance In development

DHT pilot: DECODE decision support system for the identification of dementia

In development [GID-MT536] Expected publication date: TBC

Medical technologies guidance In development

Ticagrelor for preventing cardiovascular events in people with type 2 diabetes and coronary artery disease [ID1514]

In development [GID-TA10429] Expected publication date: TBC

Technology appraisal guidance In development

Transcranial magnetic stimulation for auditory hallucinations

In development [GID-IPG10141] Expected publication date: TBC

Interventional procedures guidance In development

Neratinib for treating HER2-positive breast cancer after 2 therapies [ID1381]

In development [GID-TA10539] Expected publication date: TBC

Technology appraisal guidance In development

Selective internal radiation therapies for treating hepatocellular carcinoma [ID1276]

In development [GID-TA10381] Expected publication date: TBC

Technology appraisal guidance In development

Barrett's oesophagus: ablative therapy

In development [GID-NG10165] Expected publication date: 17 August 2022

NICE guideline In development

Olaparib with bevacizumab for maintenance treatment of advanced ovarian, fallopian tube or primary peritoneal cancer [ID1652]

In development [GID-TA10526] Expected publication date: 18 November 2020

Technology appraisal guidance In development

Lung transplantation with ex-vivo perfusion

In development [GID-IP1046] Expected publication date: TBC

Interventional procedures guidance In development

The V.A.C. Veraflo Therapy system for infected wounds

In development [GID-MT543] Expected publication date: 06 October 2020

Medical technologies guidance In development

PredictSURE-IBD and IBDX to guide personalised treatment of Crohn's disease

In development [GID-DG10029] Expected publication date: 26 August 2020

Diagnostics guidance In development

Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer (CDF Review TA600) ID1683

In development [GID-TA10537] Expected publication date: 12 August 2020

Technology appraisal guidance In development

Niraparib for maintenance treatment of platinum-sensitive ovarian, fallopian tube and peritoneal cancer after response to 1 course of platinum-based chemotherapy [ID1680]

In development [GID-TA10551] Expected publication date: 03 February 2021

Technology appraisal guidance In development

Nivolumab for previously treated locally advanced or metastatic non-squamous non-small-cell lung cancer (CDF review TA484) [ID1572]

In development [GID-TA10513] Expected publication date: 06 May 2020

Technology appraisal guidance In development

Nivolumab for previously treated squamous non-small-cell lung cancer (CDF Review TA483) [ID1559]

In development [GID-TA10516] Expected publication date: 06 May 2020

Technology appraisal guidance In development

Fetal alcohol spectrum disorder

In development [GID-QS10139] Expected publication date: 31 July 2020

Quality standard In development

Head injury: assessment and early management

In development [GID-NG10164] Expected publication date: 02 December 2021

NICE guideline In development

Obesity: identification, assessment and management

In development [GID-NG10157] Expected publication date: 23 June 2022

NICE guideline In development

Tobacco: preventing uptake, promoting quitting and treating dependence (update)

In development [GID-NG10086] Expected publication date: 18 January 2021

NICE guideline In development

End of life care (QS update)

In development [GID-QS10140] Expected publication date: 10 December 2020

Quality standard In development

Maternal health

In development [GID-QS10077] Expected publication date: TBC

Quality standard In development

School-based interventions: physical and mental health and wellbeing promotion

In development [GID-QS10070] Expected publication date: TBC

Quality standard In development

Elective joint replacement

In development [GID-QS10090] Expected publication date: 13 January 2021

Quality standard In development

Naldemedine for treating opioid-induced constipation ID1189

In development [GID-TA10291] Expected publication date: 05 June 2020

Technology appraisal guidance In development

Cabozantinib for treating advanced hepatocellular carcinoma after prior therapy [ID1243]

Technology appraisal [TA582] Published date: 24 May 2019

Technology appraisal guidance In development

Diabetic foot infection: antimicrobial prescribing

In development [GID-NG10132] Expected publication date: 11 October 2019

Antimicrobial prescribing guideline In development

Secondary infection of common skin conditions including eczema: antimicrobial prescribing

In development [GID-NG10135] Expected publication date: 10 November 2020

Antimicrobial prescribing guideline In development

Veliparib with carboplatin and paclitaxel for untreated epithelial ovarian, fallopian tube or primary peritoneal cancer ID1561

In development [GID-TA10442] Expected publication date: TBC

Technology appraisal guidance In development

Alpelisib in combination with fulvestrant for treating advanced hormone-receptor positive, HER2-negative, PIK3CA-positive breast cancer [ID1412]

In development [GID-TA10398] Expected publication date: 09 December 2020

Technology appraisal guidance In development